Graduate student, Ph.D. Candidate
B.Sc. (COOP) in Biochemistry, M. Sc. in Biochemistry
Joined in : 2015
Research project :
– Role of UGT2B17 in Chronic lymphocytic leukemia.
Nickname : Name already too short
Likes : singing
Dislikes : wasting time
Email: eric.allain.1@ulaval.ca
List of publications
Manuscripts
– Allain EP, Boudreau LH, Flamand N, Surette ME. The Intracellular Localisation and Phosphorylation Profile of the Human 5-Lipoxygenase Δ13 Isoform Differs from That of Its Full Length Counterpart. PLoS One. 2015 Jul 14;10(7):e0132607. eCollection 2015. PubMed PMID: 26173130.
Poster presentations
– The emerging role of the UGT2B17 metabolic pathway in CLL. Eric P Allain, Éric Lévesque et Chantal Guillemette. (The international workshop on conjugation, Vancouver, June 19th 2016). Poster presentation.
– UGT2B17 overexpressing CLL cells display a proliferative advantage and are characterized by distinctive gene and protein expression profiles. Eric P Allain, Éric Lévesque et Chantal Guillemette. (The Canadian CLL research meeting, Winnipeg, September 29th 2016).
– The emerging role of the UGT2B17 metabolic pathway in CLL. Eric P Allain, Éric Levèques et Chantal Guillemette. (Journée scientifique étudiante du regroupement cancer, Québec, August 18th 2016). Poster presentation. Winner of the prize for best poster presentation.
– The emerging role of the UGT2B17 metabolic pathway in CLL. Eric P Allain, Éric Levèques et Chantal Guillemette. (The Canadian CLL research meeting, Winnipeg, October 1st 2015). Poster presentation. Winner of the George D. Smith award for excellence in CLL research by a trainee.
– Le rôle de la protéine UGT2B17 dans la leucémie lymphoïde chronique. Eric P Allain, Éric Levèques et Chantal Guillemette. (Journée de l’axe Endocrinologie et Néphrologie, Québec, December 17th 2015). Poster presentation. Winner of the prize for best poster presentation.
– Le rôle de la protéine UGT2B17 dans la leucémie lymphoïde chronique. Eric P Allain, Éric Levèques et Chantal Guillemette. (57e réunion du Club de Recherches Cliniques du Québec (CRCQ), St-Alexis-des-Monts, September 24th 2015). Poster presentation.
– 5-lipoxygenase and its delta-13 isoform occupy different subcellular compartments and delta-13 inhibits leukotriene biosynthesis independently of FLAP or CLP. Eric P Allain, Luc H Boudreau, Nicolas Flamand and Marc E Surette (The 11th Biennial ISSFAL Congress, Stockholm, June 28th 2014) – Poster presentation.
– Identification d’isoformes de la 5-lipoxygenase chez des lignées cellulaires de lymphocytes B. Eric P Allain, Marc E Surette (Le 23e concours des jeunes chercheures et chercheurs, Université de Moncton, Moncton, March 21st 2012) – oral presentation, 80% of the work was done by first author.
– Allain, E.P, Boudreau L. H, Flamand N. and Surette M.E. The 6th New-Brunswick Health Research Foundation Congress, Moncton, NB. 5-lipoxygenase and its Δ13 isoform have different intracellular localisation and phosphorylation in HEK293 cells.
Oral presentations
– Allain, E.P, Surette M.E, 23e concours des jeunes chercheur(e)s de l’Université de Moncton – Identification de nouvelles isoformes de la 5-lipoxygénase humaine dans des lignées de lymphocytes B.